|
Formulation
|
No
|
50.4
|
0.0
|
0
|
0
|
2,473,000,000
|
1,591.80
|
6.44
|
|
Income from Partnership Firm
|
NA
|
37.1
|
0.0
|
0
|
0
|
0
|
1,171.58
|
-
|
|
Bulk Drugs & Chemicals
|
Kg
|
12.4
|
100.0
|
0
|
2,252,500
|
2,252,700
|
390.97
|
1,735.56
|
|
Others
|
NA
|
0.1
|
0.0
|
0
|
0
|
0
|
3.01
|
-
|
|
Lease Rental/Hire Charges
|
NA
|
0.0
|
0.0
|
0
|
0
|
0
|
0.00
|
-
|
|
Interest
|
NA
|
0.0
|
0.0
|
0
|
0
|
0
|
0.00
|
-
|
|
Bulk Drugs & Chemicals
|
KL
|
0.0
|
0.0
|
1,182
|
0
|
0
|
0.00
|
-
|
|
Tablets & Capsules
|
No
|
0.0
|
100.0
|
7,157,400,000
|
2,085,700,000
|
0
|
0.00
|
-
|
|
Conversion/Analytical Charges
|
NA
|
0.0
|
0.0
|
0
|
0
|
0
|
0.00
|
-
|
|